Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1993-8-26
pubmed:abstractText
The prognosis of patients with multifocal primary and early or multiple relapsed Ewing's sarcoma is poor with conventional chemoradiotherapy and surgery. We evaluated the efficacy and feasibility of a myeloablative regimen administered as consolidation treatment for these patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
1482-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:8101562-Adolescent, pubmed-meshheading:8101562-Adult, pubmed-meshheading:8101562-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:8101562-Bone Neoplasms, pubmed-meshheading:8101562-Carboplatin, pubmed-meshheading:8101562-Child, pubmed-meshheading:8101562-Cohort Studies, pubmed-meshheading:8101562-Combined Modality Therapy, pubmed-meshheading:8101562-Cytokines, pubmed-meshheading:8101562-Etoposide, pubmed-meshheading:8101562-Feasibility Studies, pubmed-meshheading:8101562-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:8101562-Humans, pubmed-meshheading:8101562-Melphalan, pubmed-meshheading:8101562-Prognosis, pubmed-meshheading:8101562-Recurrence, pubmed-meshheading:8101562-Remission Induction, pubmed-meshheading:8101562-Sarcoma, Ewing, pubmed-meshheading:8101562-Survival Analysis, pubmed-meshheading:8101562-Whole-Body Irradiation
pubmed:year
1993
pubmed:articleTitle
Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.
pubmed:affiliation
Department of Pediatric Hematology/Oncology, Heinrich Heine Universität, Düsseldorf, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't